for the bio-sciences sector
Oxford Optronix welcomes in 2015 with much to look forward to.
We’re committed to an initial batch of select shows and conferences at which we will be continuing to turn heads with our unique take on hypoxia workstations – the new HypoxyLab system – as well as meeting with existing and prospective clients of our hugely popular next-generation OxyLite oxygen monitors and our GelCount colony analyzer.
With in excess of 120 peer-reviewed citations and over 150 units sold worldwide, GelCount has become a true ‘gold standard’ in cancer biology colony counting.
Our latest product HypoxyLab, too, has proved popular around the world; indeed we have had to draft in additional personnel to meet demand. In the next couple of months we will be dispatching our first units to eager customers in territories outside of Europe and the US, including Brazil, Qatar, China and Russia. A good product knows no borders and we’re delighted with the response we’re seeing to our entry into this market, with a hypoxia workstation that is compact and economical, yet that sets new standards in simplicity, performance and features.
2015, we hope, will mark major milestones in our ongoing academic partnerships. Our most ambitious target is to achieve CE marking for our bladder wall oxygen monitoring technology before the end of the year, in preparation for clinical trials commencing 2016. This project is generously funded by the NIHR/Wellcome Health Innovation Challenge Fund.
We are also looking forward to reaching the proof of principle stage this year with our Wellcome Trust / EPSRC funded Acute Respiratory Distress Syndrome (ARDS) project – a long-standing collaboration between Oxford Optronix and Oxford University.
Elsewhere, we have an R&D pipeline that’s bursting at the seams. 2015 will see numerous incremental product improvements filtering through across our whole product range. These will be announced on this news page, in our newsletters, as well as on our Facebook and Twitter feeds.
It’s 2015 – the ‘future’ as envisioned in the 1989 movie “Back To The Future Part II”.
Self-tying sneakers? Hoverboards? Check out which predictions the movie got right!
WellBeing™ clinical trials commence
Happy New Year!
Ed Vaizey MP visits Oxford Optronix
Welcome to our new website!
Spring has sprung
Reflecting on 2016; looking forward to 2017
A little time Down Under…
Latest GelCount software update
Asia distributor workshop
Performance updates for HypoxyLab
Meet us at Genes & Cancer UK, Cambridge
Looking forward to a busy 2015
Oxford Optronix reaches new customers
Strategic tie-up with SciPro Inc., USA
Single-channel OxyFlo™ now shipping
GelCount™ software update
Reflections on 2013
Autumn conference round-up
Our 2013 Customer Survey results are out
Next-generation OxyLite™ and OxyFlo™ monitors